HIGHLIGHTS
- who: Chenyu Wang and collaborators from the Department of Radiotherapy, Anyang Tumor Hospital, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Henan Medical Key Laboratory of Precise Prevention and Treatment of Esophageal Cancer, Anyang, China have published the research: Real-World Efficacy and Safety of Sintilimab-Based Regimens against Advanced Esophageal Cancer: A Single-Center Retrospective Observational Study, in the Journal: BioMed Research International 2021.3.5 2021.5.27 of 19/07/2022
- what: The authors assessed the efficacy and safety of sintilimabbased regimens in patients with advanced EC.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.